Trans-aortic Valve Replacement and Renal Infarction

NCT03474250 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2018-05-01

No results posted yet for this study

Summary

Kidney Magnetic Resonance assessment before and after undergoing transcatheter aortic valve replacement

Conditions

  • Renal Infarction

Interventions

DIAGNOSTIC_TEST

Magnetic Resonance test for kidney

Magnetic Resonance test for kidney

Sponsors & Collaborators

  • Sheba Medical Center

    lead OTHER_GOV

Principal Investigators

  • Arwa Younis, Doctor · Tel Aviv University

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2018-12-31
Completion
2018-12-31
FDA Device
Yes

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03474250 on ClinicalTrials.gov